Interventional, randomized, double-blind, parallel-group, placebo-controlled study of add-on eptinezumab treatment to brief educational intervention for the preventive treatment of migraine in patients with dual diagnosis of migraine and medication overuse headache. EudraCT Number 2021-003049-40. Role: Local PI. Sponsor institution: H. Lundbeck A/S.
CandMig 3 Study - Candesartan for migraine prevention: A multicentre, binational, triple blind, placebo controlled, parallel group study of two doses of candesartan (8 and 16 mg). EudraCT Number 2019-003386-18. Role: Local PI. Sponsor institution: St. Olav’s Hospital, Trondheim.
MiBlock Study - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatmentrefractory chronic migraine: A randomized, placebo-controlled, triple-blind (blinded statistician), multicentre, parallel group proof-of-concept, phase 3 study. EudraCT Number 2018-004053-24. Role: Sub-PI. Sponsor institution: St. Olav’s Hospital and NTNU, Trondheim.
AIM Study - Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes: A double blind, randomised, placebo controlled, multicentre trial Role: Sub-PI. Sponsor institution: OUH.
Engstrand H, Revdal E, Argren MB, Hagen K, Zwart JA, Brodtkorb E, Winsvold BS(2024) Relationship between migraine and epilepsy in a large population-based cohort: The HUNT Study Eur J Neurol, e16496(in press) DOI 10.1111/ene.16496, PubMed 39331386
Hagen K, Winsvold BS, Bjørk MH, Tronvik E, Mathiesen LB, Ofte HK, Lundqvist C, Sønnervik J, Bäcklund N(2024) Room for improvement in the follow-up for unilateral headache with autonomic symptoms Tidsskr Nor Laegeforen, 144(7) DOI 10.4045/tidsskr.24.0184, PubMed 38832616
Nievergelt CM, Maihofer AX, Atkinson EG, Chen CY, Choi KW, Coleman JRI, Daskalakis NP, Duncan LE, Polimanti R, Aaronson C, Amstadter AB, Andersen SB, Andreassen OA, Arbisi PA, Ashley-Koch AE, Austin SB, Avdibegoviç E, Babić D, Bacanu SA, Baker DG, Batzler A, Beckham JC, Belangero S, Benjet C, Bergner Cet al.(2024) Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder Nat Genet, 56(5), 792-808 DOI 10.1038/s41588-024-01707-9, PubMed 38637617